Engineering Stem Cell Derived Biomimetic Vesicles for Versatility and Effective Targeted Delivery
- 11 September 2020
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 30 (49)
- https://doi.org/10.1002/adfm.202006169
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81620108028)
This publication has 60 references indexed in Scilit:
- Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?Advanced Drug Delivery Reviews, 2014
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptorProceedings of the National Academy of Sciences of the United States of America, 2013
- Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of NanoparticlesScience, 2013
- Microglial physiopathology: how to explain the dual role of microglia after acute neural disorders?Brain and Behavior, 2012
- Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct sizeJournal of Neuroinflammation, 2011
- Mesenchymal stem cells: A promising targeted-delivery vehicle in cancer gene therapyJournal of Controlled Release, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Mesenchymal Stem Cell Homing: The Devil Is in the DetailsCell Stem Cell, 2009
- Microglia Potentiate Damage to Blood–Brain Barrier ConstituentsStroke, 2006
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002